JP2002541245A5 - - Google Patents

Download PDF

Info

Publication number
JP2002541245A5
JP2002541245A5 JP2000610837A JP2000610837A JP2002541245A5 JP 2002541245 A5 JP2002541245 A5 JP 2002541245A5 JP 2000610837 A JP2000610837 A JP 2000610837A JP 2000610837 A JP2000610837 A JP 2000610837A JP 2002541245 A5 JP2002541245 A5 JP 2002541245A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
amino
pyrimidine
chlorophenoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000610837A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002541245A (ja
JP4743463B2 (ja
Filing date
Publication date
Priority claimed from US09/288,495 external-priority patent/US6583148B1/en
Application filed filed Critical
Publication of JP2002541245A publication Critical patent/JP2002541245A/ja
Publication of JP2002541245A5 publication Critical patent/JP2002541245A5/ja
Application granted granted Critical
Publication of JP4743463B2 publication Critical patent/JP4743463B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000610837A 1999-04-08 2000-04-06 神経栄養置換ピリミジン Expired - Fee Related JP4743463B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/288,495 US6583148B1 (en) 1999-04-08 1999-04-08 Neurotrophic substituted pyrimidines
US09/288,495 1999-04-08
PCT/US2000/009108 WO2000061562A1 (en) 1999-04-08 2000-04-06 Neurotrophic substituted pyrimidines

Publications (3)

Publication Number Publication Date
JP2002541245A JP2002541245A (ja) 2002-12-03
JP2002541245A5 true JP2002541245A5 (cg-RX-API-DMAC7.html) 2011-02-10
JP4743463B2 JP4743463B2 (ja) 2011-08-10

Family

ID=23107364

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000610837A Expired - Fee Related JP4743463B2 (ja) 1999-04-08 2000-04-06 神経栄養置換ピリミジン

Country Status (8)

Country Link
US (2) US6583148B1 (cg-RX-API-DMAC7.html)
EP (1) EP1165523B1 (cg-RX-API-DMAC7.html)
JP (1) JP4743463B2 (cg-RX-API-DMAC7.html)
AT (1) ATE377592T1 (cg-RX-API-DMAC7.html)
AU (1) AU4331400A (cg-RX-API-DMAC7.html)
CA (1) CA2368843C (cg-RX-API-DMAC7.html)
DE (1) DE60037013T2 (cg-RX-API-DMAC7.html)
WO (1) WO2000061562A1 (cg-RX-API-DMAC7.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5154728B2 (ja) * 2000-07-24 2013-02-27 クレニツキー・ファーマシューティカルズ,インコーポレイテッド 神経栄養活性を有する置換5−アルキニルピリミジン
CN1324015C (zh) 2002-02-13 2007-07-04 霍夫曼-拉罗奇有限公司 吡啶-和嘧啶-衍生物
JP2005232081A (ja) * 2004-02-19 2005-09-02 Bayer Cropscience Ag ベンジルピリミジン誘導体の農園芸用殺菌剤としての利用
PT1725540E (pt) 2004-03-05 2012-11-29 Hoffmann La Roche Diaminopirimidinas como antagonistas de p2x3 e p2x2/3
US20110230479A1 (en) * 2005-04-15 2011-09-22 Longo Frank M Neurotrophin mimetics and uses thereof
WO2006113097A2 (en) * 2005-04-15 2006-10-26 The University Of North Carolina At Chapel Hill Methods of facilitating cell survival using neurotrophin mimetics
EP2581440B1 (en) * 2005-06-08 2016-03-16 The University of North Carolina At Chapel Hill Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics
ES2562056T3 (es) 2005-09-01 2016-03-02 F. Hoffmann-La Roche Ag Diaminopirimidinas como moduladores P2X3 y P2X2/3
SI1924264T1 (sl) * 2005-09-01 2013-12-31 F. Hoffmann-La Roche Ag Diaminopirimidini kot modulatorji p2x3 in p2x2/3
ES2612890T3 (es) * 2005-09-01 2017-05-19 F. Hoffmann-La Roche Ag Diaminopirimidinas como moduladores de P2X3 y P2X2/3
AU2006286576B2 (en) * 2005-09-01 2012-06-14 F. Hoffmann-La Roche Ag Diaminopyrimidines as P2X3 and P3X2/3 modulators
WO2007125952A1 (ja) * 2006-04-28 2007-11-08 Shionogi & Co., Ltd. Npy y5受容体拮抗作用を有するアミン誘導体
RU2433119C2 (ru) * 2006-04-28 2011-11-10 Шионоги Энд Ко., Лтд. Производное амина, обладающее антагонистической активностью в отношении рецептора npy y5
CN101479238B (zh) * 2006-04-28 2013-08-21 盐野义制药株式会社 具有npyy5受体拮抗活性的胺衍生物
SA08290668B1 (ar) 2007-10-25 2012-02-12 شيونوجي آند كو.، ليمتد مشتقات أمين لها نشاط مضاد لمستقبل npy y5 واستخداماتها
US8227618B2 (en) 2009-04-23 2012-07-24 Shionogi & Co., Ltd. Amine-derivatives having NPY Y5 receptor antagonistic activity and the uses thereof
WO2011060262A1 (en) 2009-11-12 2011-05-19 Pharmatrophix, Inc. Crystalline forms of neurotrophin mimetic compounds and their salts
US10273219B2 (en) 2009-11-12 2019-04-30 Pharmatrophix, Inc. Crystalline forms of neurotrophin mimetic compounds and their salts
ES2691745T3 (es) * 2011-04-08 2018-11-28 Janssen Sciences Ireland Uc Derivados de pirimidina para el tratamiento de infecciones víricas
DK2776439T3 (en) 2011-11-09 2018-10-22 Janssen Sciences Ireland Uc PURINE DERIVATIVES FOR TREATING VIRUS INFECTIONS
DK2872515T3 (en) 2012-07-13 2016-09-19 Janssen Sciences Ireland Uc MACROCYCLIC PURINES FOR TREATING VIRUS INFECTIONS
JP6302906B2 (ja) * 2012-08-10 2018-03-28 ヤンセン・サイエンシズ・アイルランド・ユーシー ウイルス感染および他の疾患を治療するためのアルキルピリミジン誘導体
MX386924B (es) 2012-10-10 2025-03-19 Janssen Sciences Ireland Uc Derivados pirrolo[3,2-d]pirimidínicos para el tratamiento de infecciones víricas y otras enfermedades.
US9663474B2 (en) 2012-11-16 2017-05-30 Janssen Sciences Ireland Uc Heterocyclic substituted 2-amino quinazoline derivatives for the treatment of viral infections
KR102300861B1 (ko) 2013-02-21 2021-09-10 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 바이러스 감염의 치료를 위한 2-아미노피리미딘 유도체
US9828330B2 (en) 2013-03-15 2017-11-28 Pharmatrophix, Inc. Non-peptide BDNF neurotrophin mimetics
CA2901839A1 (en) 2013-03-15 2014-09-18 Pharmatrophix, Inc. Non-peptide bdnf neurotrophin mimetics
WO2014154859A1 (en) 2013-03-29 2014-10-02 Janssen R&D Ireland Macrocyclic deaza-purinones for the treatment of viral infections
UA117586C2 (uk) 2013-05-24 2018-08-27 ЯНССЕН САЙЄНСІЗ АЙРЛЕНД ЮСі Похідні піридину для лікування вірусних інфекцій та інших захворювань
MX392130B (es) 2013-06-27 2025-03-21 Janssen Sciences Ireland Uc Derivados de pirrolo[3,2-d]pirimidina para el tratamiento de infecciones víricas y otras enfermedades.
ES2836881T3 (es) 2013-07-30 2021-06-28 Janssen Sciences Ireland Unlimited Co Derivados de tieno[3,2-d]pirimidinas para el tratamiento de infecciones virales
MA45539A (fr) 2016-07-01 2019-05-08 Janssen Sciences Ireland Unlimited Co Dihydropyranopyrimidines pour le traitement d'infections virales
SG10202010317VA (en) 2016-09-29 2020-11-27 Janssen Sciences Ireland Unlimited Co Pyrimidine prodrugs for the treatment of viral infections and further diseases
TW202415645A (zh) 2018-03-01 2024-04-16 愛爾蘭商健生科學愛爾蘭無限公司 2,4-二胺基喹唑啉衍生物及其醫學用途
TWI815954B (zh) 2018-08-27 2023-09-21 日商住友製藥股份有限公司 光學活性氮雜雙環衍生物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2691655A (en) 1952-05-24 1954-10-12 Burroughs Wellcome Co 2-amino-4-substituted amino-6-aryl pyrimidines and process of preparing same
GB951431A (en) 1959-03-17 1964-03-04 Wellcome Found Pyrimidine derivatives and the manufacture thereof
US3862190A (en) 1972-09-08 1975-01-21 Pfizer 5-(unsubstituted and substituted phenoxy)-4-amino pyrimidines
DK397574A (cg-RX-API-DMAC7.html) * 1973-08-24 1975-04-28 Ciba Geigy Ag
GB1523274A (en) 1974-08-05 1978-08-31 Ici Ltd Herbicidal compositions containing substituted pyrimidine
FR2358148A1 (fr) 1976-07-12 1978-02-10 Dick Pr Derives de 2,4-diaminopyrimidines et leur mise en solution en association avec des sulfamides
FR2397407A2 (fr) 1977-07-11 1979-02-09 Dick Pierre Derives de 2,4-diamino pyrimidines et leur mise en solution en association avec des sulfamides
FI895821A7 (fi) 1988-12-07 1990-06-08 The Wellcome Foundation Ltd Farmaseuttisesti aktivisia CNS-yhdisteitä
GB9012316D0 (en) 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
IE912114A1 (en) 1990-07-02 1992-01-15 Union Pharma Scient Appl Novel pyrimidine derivatives which are angiotensin ii¹receptor antagonists, their methods of preparation and¹pharmaceutical compositions in which they are present
US5075305A (en) 1991-03-18 1991-12-24 Warner-Lambert Company Compound, composition and use
DE69201559T2 (de) 1991-04-17 1995-07-13 Pfizer Pyrimidinderivate zur erhöhung der antitumoraktivität.
US5336677A (en) 1991-10-24 1994-08-09 American Home Products Corporation Substituted aminopyrimidines as antihypertensives
GB9125842D0 (en) 1991-12-04 1992-02-05 Ici Plc Heterocyclic derivatives
EP0674627A1 (en) 1992-12-18 1995-10-04 The Wellcome Foundation Limited Pyrimidine, pyridine, pteridinone and indazole derivatives as enzyme inhibitors
EP0640599B1 (en) 1993-08-26 1998-03-04 Ono Pharmaceutical Co., Ltd. 4-Aminopyrimidine derivatives
JPH08283246A (ja) 1994-06-01 1996-10-29 Nippon Soda Co Ltd ピリミジン誘導体、その製造方法及び有害生物防除剤
EP0826674A4 (en) 1995-04-03 1998-07-08 Sumitomo Pharma EFFECTIVE PYRIMIDINE DERIVATIVES AS PSYCHOTROPE, AND METHOD FOR THE PRODUCTION THEREOF
US6440965B1 (en) 1997-10-15 2002-08-27 Krenitsky Pharmaceuticals, Inc. Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system

Similar Documents

Publication Publication Date Title
RU2356891C2 (ru) Производные пиридинкарбоксамида и их соли для применения в качестве инсектицида
RU2475487C2 (ru) Имидазохинолины с иммуномодулирующими свойствами
RU2012108173A (ru) Терапевтические арил-амидо-арильные соединения и их применение
CA2431952A1 (en) Muscarinic antagonists
RU2007139453A (ru) Гетеробициклические ингибиторы вируса гепатита с (hcv)
CA2445395A1 (en) Heterocyclic compound and antitumor agent comprising the same as effective component
NO20051303L (no) Nye benzoimidazolderivater nyttige som antiproliferative midler
FI973446A0 (fi) Bentsyylipiperidiinit ja piperatsiinit muskariiniantagonisteina
EP2597087A1 (en) Dihydrooxazine and tetrahydropyrimidine derivatives as BACE 1 inhibitors
PE20040079A1 (es) Derivados de indolilmaleimida
CA2416442A1 (en) Substituted 5-alkynyl pyrimidines having neurotrophic activity
AR047339A1 (es) Derivados de difenilazetidona.proceso de obtencion.
HUT60733A (en) Process for producing new n-(4-piperidinyl)-(dihydrobenzofuran or dihydro-2h-benzopyran)-carboxamide derivatives and pharmaceutical compositions comprising such compounds
CA2503451A1 (en) Heterocyclic compounds and antitumor agent comprising the same as effective component
DE60303954D1 (de) Chinolyl-propylpiperidinderivate und deren verwendung als antimikrobielle wirkstoffe
NO20072409L (no) Substituerte n-sulfonylaminobenzyl-2-fenoksy acetamid-forbindelser
MY133108A (en) Muscarinic antagonists
NZ307505A (en) Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
RU2007147344A (ru) Новые производные 2-азетидинона для лечения гиперлипидемических заболеваний
RU2007147346A (ru) Новые производные 2-азетидинона в качестве ингибиторов всасывания холестерина для лечения гиперлипидемических состояний
AR054482A1 (es) Derivados de azetidinona para el tratamiento de hiperlipidemias
FR2844270B1 (fr) Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
RU2007147341A (ru) Новые производные 2-азетидинона в качестве ингибиторов всасывания холестерина для лечения гиперлипидемических состояний
RU97103983A (ru) Лекарственные композиции и производные триазина
RU2004126957A (ru) Пиперидиновые производные